Drug Landscape ›
Vitamin E, Vitamin C ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 14
Most-reported reactions
Atrial Fibrillation — 2 reports (14.29%) Death — 2 reports (14.29%) Diarrhoea — 2 reports (14.29%) Headache — 2 reports (14.29%) Asthenia — 1 report (7.14%) Chest Discomfort — 1 report (7.14%) Chills — 1 report (7.14%) Colitis — 1 report (7.14%) Cough — 1 report (7.14%) Dizziness — 1 report (7.14%)
Source database →
Vitamin E, Vitamin C in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Vitamin E, Vitamin C approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Vitamin E, Vitamin C in United States?
Sir Takhtasinhji General Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.